UFP Technologies (NASDAQ:UFPT) delivers impressive Q3 2026

UFP Technologies (UFPT) reported Q3 sales of $172.43M and net income of $20.62M, up from the previous year. Shares rose 17.66% to $329.82 on the news, extending a 15.32% 7-day return. Analysts see a fair value of $355, citing growth in medical device components and packaging. However, UFPT trades at 33.4x earnings, higher than the industry average of 23.9x, raising valuation concerns.

Lyell Immunopharma (LYEL) rose 44% after securing $80M in financing and reporting positive clinical data. LivaNova (LIVN) gained 23% on strong Q3 results and raised guidance. UFP Technologies (UFPT) advanced 22% with 11.6% sales growth and improved profitability. Neuronetics (STIM) rose 21% as Q3 loss narrowed and EBITDA turned positive.

UFP Technologies (UFPT) reported Q3 2026 sales up 11.6%, with organic growth at 11.1%. Gross margin improved to 29.4% from 27.7% last year. Adjusted EPS was $2.88, up significantly. The company is investing in growth, including acquisitions like CI Medical, and expanding credit facilities. AJR operations are behind schedule but expected to improve in 2027. Management remains optimistic about long-term growth and shareholder value.

UFP TECHNOLOGIES INC (UFPT) filed an SEC Form 8-K — Results of Operations and Financial Condition. UFP Technologies Announces Strong Q3 Results Newburyport, Mass., November 3, 2026. UFP Technologies, Inc. (Nasdaq: UFPT), a trusted contract development and manufacturing organization specializing in comprehensive solutions for medical devices, sterile packaging and other highly

UFP Technologies, Inc. (UFPT) completed the acquisition of CI Medical Inc. on September 7, 2026. The company's stock has seen a 5-day change of 288.79 USD, a 1st Jan change of +0.79%, and a year-to-date change of +30.07%.

UFP Technologies (UFPT) reported record Q2 profits of $20.9M, up 21.4% YoY, with net sales of $174.0M, up 15.1%. Gross margin rose to 29.3%, but SG&A expenses increased 21.8%, raising concerns. CEO noted near-term margin pressure due to Dominican Republic operations. Hedge fund interest declined, and short interest is high at 19.26% of float.